As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The ...

NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule ...

Guggenheim analyst Yatin Suneja downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a $20 price target Published first on TheFly – ...

Guggenheim named MSG Entertainment (MSGE) as a best idea entering 2025. Shares have slid about 23% since fiscal Q1 earnings ...

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by Guggenheim from a “buy” rating to a “neutral” rating ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

Investing.com -- Guggenheim named Madison Square Garden Sports Corp (NYSE:MSGS) its "best idea" for 2025 given strong secular ...

As previously reported, Guggenheim analyst Michael Morris initiated coverage of Reddit (RDDT) with a Buy rating and $210 ...

Guggenheim Active Allocation Fund (NYSE:GUG – Get Free Report) shares fell 0.5% during trading on Wednesday . The company traded as low as $14.78 and last traded at $14.87. 191,595 shares changed ...

With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...

Absci Corp (ABSI) stock saw a decline, ending the day at $2.65 which represents a decrease of $-0.12 or -4.33% from the prior close of $2.77. The stock opened at $2.72 and touched a low of $2.62 ...